| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.32 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.25 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.38 | 0.02 |